KS
Kevin R Sayer
Executive ChairDirector

Kevin R Sayer insider trades: Dexcom (DXCM) stock sales

Executive Chair, Dexcom Last trade Aug 20, 2026 121 Form 4 filings
$8.3M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
81
Open-market trades
since 2012
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

81 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 20, 2026DXCM↓ Sell10b5-1$2.4M
Jul 20, 2026DXCM↓ Sell10b5-1$2.0M
Jul 6, 2026DXCM↓ Sell10b5-1$1.9M
May 21, 2026DXCM↓ Sell10b5-1$1.9M
Mar 12, 2025DXCM↓ Sell$2.3M
Jan 29, 2025DXCM↓ Sell$2.9M
Apr 8, 2024DXCM↓ Sell10b5-1$6.9M
Mar 12, 2024DXCM↓ Sell10b5-1$10.8M
Jan 16, 2024DXCM↓ Sell$4.6M
Apr 3, 2023DXCM↓ Sell10b5-1$2.4M
Mar 1, 2023DXCM↓ Sell10b5-1$4.2M
Jan 30, 2023DXCM↓ Sell10b5-1$6.0M
Jan 20, 2023DXCM↓ Sell$4.8M
Mar 15, 2022DXCM↓ Sell10b5-1$1.2M
Feb 14, 2022DXCM↓ Sell10b5-1$1.3M
Jan 18, 2022DXCM↓ Sell10b5-1$9.9M
Dec 15, 2021DXCM↓ Sell10b5-1$1.6M
Nov 15, 2021DXCM↓ Sell10b5-1$1.9M
Oct 15, 2021DXCM↓ Sell10b5-1$3.3M
Sep 15, 2021DXCM↓ Sell10b5-1$3.2M
Sep 9, 2021DXCM↓ Sell$1.6M
May 3, 2021DXCM↓ Sell10b5-1$2.1M
Apr 5, 2021DXCM↓ Sell10b5-1$2.3M
Mar 10, 2021DXCM↓ Sell$5.1M
Mar 9, 2021DXCM↓ Sell10b5-1$1.4M
Feb 1, 2021DXCM↓ Sell10b5-1$4.7M
Jan 13, 2021DXCM↓ Sell10b5-1$17.0M
Dec 1, 2020DXCM↓ Sell10b5-1$4.3M
Oct 29, 2020DXCM↓ Sell10b5-1$4.7M
Sep 9, 2020DXCM↓ Sell$4.0M
Jul 6, 2020DXCM↓ Sell10b5-1$2.5M
Jun 1, 2020DXCM↓ Sell10b5-1$2.3M
May 4, 2020DXCM↓ Sell10b5-1$2.1M
Apr 7, 2020DXCM↓ Sell10b5-1$1.6M
Mar 11, 2020DXCM↓ Sell$5.4M
Mar 9, 2020DXCM↓ Sell10b5-1$1.6M
Feb 10, 2020DXCM↓ Sell10b5-1$1.5M
Jan 13, 2020DXCM↓ Sell10b5-1$1.4M
Dec 2, 2019DXCM↓ Sell10b5-1$2.2M
Nov 4, 2019DXCM↓ Sell10b5-1$1.6M
Oct 1, 2019DXCM↓ Sell10b5-1$1.5M
Sep 9, 2019DXCM↓ Sell$2.1M
Sep 3, 2019DXCM↓ Sell10b5-1$1.7M
Aug 15, 2019DXCM↓ Sell10b5-1$1.6M
Jul 8, 2019DXCM↓ Sell10b5-1$877K
Jun 10, 2019DXCM↓ Sell10b5-1$796K
May 13, 2019DXCM↓ Sell10b5-1$694K
Apr 15, 2019DXCM↓ Sell10b5-1$713K
Mar 12, 2019DXCM↓ Sell10b5-1$4.7M
Feb 11, 2019DXCM↓ Sell10b5-1$893K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DXCM insiders

Open-market trades in the last 12 months

About Kevin R Sayer's insider trades

Kevin R Sayer is Executive Chair at Dexcom (DXCM). Since Jun 4, 2012, Kevin has reported no open-market purchases and 81 sales worth $194.1M on SEC Form 4. In the last 12 months: 4 sales ($8.3M).

65 sales (78% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (27 filings), shares returned to the company (20 filings), option exercises (12 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DXCM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.